1. Home
  2. EMBJ vs PCVX Comparison

EMBJ vs PCVX Comparison

Compare EMBJ & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

EMBJ

Embraer S.A.

N/A

Current Price

$62.79

Market Cap

9.9B

Sector

Industrials

ML Signal

N/A

Logo Vaxcyte Inc.

PCVX

Vaxcyte Inc.

HOLD

Current Price

$57.36

Market Cap

8.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EMBJ
PCVX
Founded
1969
2013
Country
Brazil
United States
Employees
20744
N/A
Industry
Aerospace
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.9B
8.6B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
EMBJ
PCVX
Price
$62.79
$57.36
Analyst Decision
Buy
Strong Buy
Analyst Count
1
4
Target Price
$84.00
$88.25
AVG Volume (30 Days)
1.2M
986.9K
Earning Date
05-05-2026
05-07-2026
Dividend Yield
0.35%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$13.60
N/A
P/E Ratio
$159.30
N/A
Revenue Growth
N/A
N/A
52 Week Low
$54.28
$28.09
52 Week High
$80.75
$65.00

Technical Indicators

Market Signals
Indicator
EMBJ
PCVX
Relative Strength Index (RSI) 45.69 43.61
Support Level $60.76 $52.04
Resistance Level $65.81 $58.95
Average True Range (ATR) 2.03 2.05
MACD -0.48 -0.61
Stochastic Oscillator 18.06 19.29

Price Performance

Historical Comparison
EMBJ
PCVX

About EMBJ Embraer S.A.

Embraer SA based in Sao Paulo, Brazil, manufacturer of jets. Its focus is to achieve customer satisfaction with and services addressing the commercial airline, executive jets, and defense and security markets. It has developed a customer-centric technology-driven portfolio of commercial aviation products and services that allows it to build long-term relationships with clients in the commercial aviation, executive jets, and defense and security markets. It operates through the various segments namely Commercial Aviation, Defense and Security, Executive Aviation, Service and Support, and Other Segments. The company generates maximum revenue from the Commercial Aviation segment.

About PCVX Vaxcyte Inc.

Vaxcyte Inc is a clinical-stage vaccine company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It uses the XpressCF cell-free protein synthesis platform to develop potentially superior and novel conjugate and protein vaccine candidates for adult and pediatric indications. The company's product pipeline includes: VAX-31, VAX-24, and VAX-XL PCV vaccine candidates; VAX-A1, a Novel Group A Strep Vaccine; and VAX-GI, a Novel Shigella Vaccine, among others, in their different stages of development.

Share on Social Networks: